Skip to main content
. 2016;20(4):241–245. doi: 10.7508/ibj.2016.04.009

Table 1.

Distribution of BIRC5 CNVs in association with clinicopathological characteristics

Clinicopathological characteristics BIRC5 amplification (Number=7) (%) P value No BIRC5 amplification (Number=33) (%) P value
Stage
 I 0 (0) 0.6 2 (5) 0.6
 II 5 (12.5) 18 (45)
 III 2 (5) 13 (32.5)
 IV 0 (0) 0 (0)
Grade
 I 2 (5) 0.2 12 (30) 0.5
 II 4 (10) 13(32.5)
 III 1 (2.5) 8 (20)
Age
 ≤40 5 (12.5) 0.04 6 (15) 0.3
 >40 2 (5) 27 (67)
Tumor size (cm)
 ≤2 0 (0) 0.4 6 (15) 0.6
 2<T≤5 5 (12.5) 23 (57)
 >5 2 (5) 4 (10)